Top

Applied Health Economics and Health Policy

Published in:

Open Access 01-02-2019 | Original Research Article

Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations

Authors: Judith J. Gout-Zwart, Erien H. J. Olde Hengel, Petra Hoogland, Maarten J. Postma

Published in: Applied Health Economics and Health Policy | Issue 1/2019

Abstract

Objectives

Medication errors that lead to adverse drug reactions are a key cause of unintentional patient harm and subsequent economic burden. To prevent this, measurement of renal function could be considered. The aim of this study was to determine the budget impact of obtaining and evaluating renal function in community pharmacies in the Netherlands to prevent antibiotic-related hospitalizations.

Methods

A decision model was built to simulate the process of antibiotic prescriptions in community pharmacies with and without the use of a point-of-care test (PoCT) in patients aged 65 years and older. By using a PoCT, the number of patients with renal function values available increases, leading to the possibility of dose adjustment when necessary. In turn, this might avoid hospitalizations. For this study, real-life patient data were used from 351 community pharmacies. Direct costs of renal function screening, antibiotic treatments, and medical care due to antibiotic-related hospitalization were included.

Results

The budget impact analysis showed annual cost-savings of €86 per patient through the availability of renal function values in Dutch community pharmacies. Savings were mostly due to avoided hospitalizations.

Conclusion

Obtaining and evaluating renal function in community pharmacies by point of care tests is expected to be cost-saving in the Netherlands.

Available only for authorised users

Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PML. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890–6. https://doi.org/10.1016/S0084-3873(09)79549-5.CrossRefPubMed

Verbeeck RK, Musuamba FT. Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol. 2009;65(8):757–73. https://doi.org/10.1007/s00228-009-0678-8.CrossRefPubMed

Projectplan Nierfunctieproject 2015–2016. Service Apotheken. 2016.

Heringa M, van de Steeg-van Gompel CH, Bouvy ML. Medisch-Farmaceutische Beslisregels En Nierfunctiemeting in de Openbare Apotheek: Wat Levert Het Op? Netherlands; 2017. Available at https://www.knmp.nl/professie/wetenschap/nederlands-platform-voor-farmaceutisch-onderzoek/medisch-farmaceutische-beslisregels-en-nierfunctiemeting-in-de-openbare-apotheek-wat-levert-het-op.

Joosten H, Drion I, Boogerd KJ, van der Pijl EV, Slingerland RJ, Slaets JPJ, et al. Optimising drug prescribing and dispensing in subjects at risk for drug errors due to renal impairment: improving drug safety in primary healthcare by low eGFR alerts. BMJ Open. 2013;3(1):e002068. https://doi.org/10.1136/bmjopen-2012-002068.CrossRefPubMedPubMedCentral

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HIA, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefPubMedPubMedCentral

Koster ES, Philbert D, Noordam M, Winters NA, Blom L, Bouvy ML. Availability of information on renal function in Dutch community pharmacies. Int J Clin Pharm. 2016;38(4):797–801. https://doi.org/10.1007/s11096-016-0332-3.CrossRefPubMed

Van Hilten O MA. Figures in health and healthcare 2007. Voorburg/Heerlen CBS, 2007.

Heringa M, Floor-Schreudering A, De Smet PAGM, Bouvy ML. Clinical decision support and optional point of care testing of renal function for safe use of antibiotics in elderly patients: a retrospective study in community pharmacy practice. Drugs Aging. 2017;34(11):851–8. https://doi.org/10.1007/s40266-017-0497-z.CrossRefPubMedPubMedCentral

10.

Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health. 2007;10(5):336–47. https://doi.org/10.1111/j.1524-4733.2007.00187.x.CrossRefPubMed

11.

Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M, et al. Budget impact analysis—principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health. 2014;17(1):5–14. https://doi.org/10.1016/j.jval.2013.08.2291.CrossRefPubMed

12.

Nova Biomedical: StatSensor^® Point-of-Care Creatinine and eGFR Analyzers. Available at http://www.novabio.us/statstrip-creatinine/. Accessed July 2, 2018.

13.

VZVZ—Over het LSP. Available at https://www.vzvz.nl/over-het-lsp. Accessed July 2, 2018.

14.

Vemer P, Corro Ramos I, van Voorn GAK, Al MJ, Feenstra TL. AdViSHE: a validation-assessment tool of health-economic models for decision makers and model users. Pharmacoeconomics. 2016;34(4):349–61. https://doi.org/10.1007/s40273-015-0327-2.CrossRefPubMed

15.

Royal Dutch Pharmacists Association (Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie). KNMP Nierfunctie. Knmp. 2014. Available at https://www.knmp.nl/downloads/g-standaard/informatie-verminderde-nierfunctie.pdf/view. Accessed 17 Feb 2017.

16.

Royal Dutch Pharmacists Association. Knowledge base (KNMP Kennisbank). Available at kennisbank.knmp.nl. Accessed 12 Dec 2017.

17.

National Health Care Institute. Farmacotherapeutisch Kompas. Available at https://www.farmacotherapeutischkompas.nl/. Accessed July 9, 2018.

18.

National Health Care Institute. Medicijnkosten. Available at https://www.medicijnkosten.nl/. Accessed 3 May 2017.

19.

Hakkaart-van Roijen L, Van der Linden N, Bouwmans CAM, Kanters TA, Tan SS. Costing manual: methodology of costing research and reference prices for economic evaluations in healthcare (Kostenhandleiding: methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg). 2015.

20.

Statistics Netherlands (Centraal Bureau voor de Statistiek) - Consumer price index, annual mutations. Available at statline.cbs.nl. Accessed 2 July 2018.

21.

Service Apotheek. Available at https://www.serviceapotheek.nl/service. Accessed July 6, 2018.

22.

Menarini Diagnostics. Available at http://www.menarinidiagnostics.nl/. Accessed July 6, 2018.

23.

Foundation for Pharmaceutical Statistics (Stichting Farmaceutische Kengetallen). Overname leidt vooral tot minder formuleapotheken. Pharm Weekbl. 2017;152:9.

24.

Geerts AFJ, De Koning FHP, De Vooght KMK, Egberts ACG, De Smet PAGM, van Solinge WW. Feasibility of point-of-care creatinine testing in community pharmacy to monitor drug therapy in ambulatory elderly patients. J Clin Pharm Ther. 2013;38(5):416–22. https://doi.org/10.1111/jcpt.12081.CrossRefPubMed

25.

Leendertse AJ, van Dijk EA, De Smet PA, Egberts TC, van den Bemt PM. Contribution of renal impairment to potentially preventable medication-related hospital admissions. Ann Pharmacother. 2012;46(5):625–33.CrossRefPubMed

Title: Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations
Authors: Judith J. Gout-Zwart
Erien H. J. Olde Hengel
Petra Hoogland
Maarten J. Postma
Publication date: 01-02-2019
Publisher: Springer International Publishing
Published in: Applied Health Economics and Health Policy / Issue 1/2019
Print ISSN: 1175-5652
Electronic ISSN: 1179-1896
DOI: https://doi.org/10.1007/s40258-018-0426-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations

Abstract

Objectives

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2019

Did we see it Coming? An Evaluation of the Swedish Early Awareness and Alert System

Comment on: “Does MCDA Trump CEA?”

The Economic Burden of Chronic Obstructive Pulmonary Disease in Greece

Cost-Effectiveness of Scaling Up Modern Family Planning Interventions in Low- and Middle-Income Countries: An Economic Modeling Analysis in Indonesia and Uganda

The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents

Peristeen Transanal Irrigation System to Manage Bowel Dysfunction: A NICE Medical Technology Guidance